Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in the UAE.

Home | go to homepage
SCIENCE
  • SCIENCE
  • Cardiovascular
    • Cardiovascular
    • Thrombosis
    • Dyslipidemia
    • Atherothrombosis
  • Atopic Dermatitis
  • Diabetes
  • Asthma
  • Nasal Polyps
  • Rare Diseases
  • Vaccines
    • Vaccines
    • Influenza
    • Pertussis & Polio
    • Meningitis
  • Multiple Sclerosis
  • Prurigo Nodularis
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Diabetes
    • Diabetes
    • Tools And Resources
      • Tools And Resources
      • Digital Patient Support Program
      • Pre-Ramadan Assessment Tools
      • Toujeo Welcome Pack
      • Soliqua Welcome Pack
  • Atopic Dermatitis
  • Rare Diseases
  • Nasal Polyps
  • Cardiovascular
    • Cardiovascular
    • Dyslipidemia
PRODUCTS
  • PRODUCTS
  • Dupixent®
    • Dupixent®
    • Atopic Dermatitis
    • Asthma
    • Nasal Polyps
  • Clexane®
  • Plavix®
  • Zympass®
  • Apidra®
  • Soliqua®
    • Soliqua®
    • Soliqua®
    • SoliMix Study
    • For a Peaceful Ramadan
  • Toujeo®
    • Toujeo®
    • Toujeo®
    • For a Peaceful Ramadan
    • Time-in-Range
  • Lantus®
  • Praluent®
    • Praluent®
    • Praluent®
    • Praluent 300 mg
  • Aubagio®
  • Depakine®
  • Lemtrada®
  • Amaryl®
  • Aprovel®
Home | go to homepage
Home | go to homepage
SCIENCE
  • SCIENCE
  • Cardiovascular
    • Cardiovascular
    • Thrombosis
    • Dyslipidemia
    • Atherothrombosis
  • Atopic Dermatitis
  • Diabetes
  • Asthma
  • Nasal Polyps
  • Rare Diseases
  • Vaccines
    • Vaccines
    • Influenza
    • Pertussis & Polio
    • Meningitis
  • Multiple Sclerosis
  • Prurigo Nodularis
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Diabetes
    • Diabetes
    • Tools And Resources
      • Tools And Resources
      • Digital Patient Support Program
      • Pre-Ramadan Assessment Tools
      • Toujeo Welcome Pack
      • Soliqua Welcome Pack
  • Atopic Dermatitis
  • Rare Diseases
  • Nasal Polyps
  • Cardiovascular
    • Cardiovascular
    • Dyslipidemia
PRODUCTS
  • PRODUCTS
  • Dupixent®
    • Dupixent®
    • Atopic Dermatitis
    • Asthma
    • Nasal Polyps
  • Clexane®
  • Plavix®
  • Zympass®
  • Apidra®
  • Soliqua®
    • Soliqua®
    • Soliqua®
    • SoliMix Study
    • For a Peaceful Ramadan
  • Toujeo®
    • Toujeo®
    • Toujeo®
    • For a Peaceful Ramadan
    • Time-in-Range
  • Lantus®
  • Praluent®
    • Praluent®
    • Praluent®
    • Praluent 300 mg
  • Aubagio®
  • Depakine®
  • Lemtrada®
  • Amaryl®
  • Aprovel®
  • LOGIN
  • REGISTER
  • SEARCH
    • Home
    • Science
    • Inspiration and Innovation

    Inspiration and Innovation

    Get inspired and stay on the cutting edge of innovation with these resources.

    Risk factors of lower extremity DVT in patients undergone gynecological laparoscopic surgery

    Evaluation of comparative efficacy and safety of thromboprophylaxis agents among critically ill patients

    Risk for thromboembolic and bleeding events in patients with haematological cancers

    VTE Comparison of Pregnancy-Specific Risk Scoring Systems in Hospitalized Maternity Patients

    Utility of Pregnancy-Adapted YEARS Algorithm in Diagnosis of Pulmonary Embolism

    Impact of anemia on long-term clinical outcomes in VTE

    Safety of preoperative LMWH in lung cancer patients

    Clexane Story: 30 Years Of Flowing Life NFC video

    Clexane Story: 30 Years Of Flowing Life

    HEART UK reviews safety of lipid-lowering medications in patients with COVID-19

    Switching from statin monotherapy to statinezetimibe combination

    Treating to target in clinical practice: Why is it important to achieve recommended LDL-C levels?

    1
    2
    3
    4
    5
    6
    7
    8
    9
    Home | go to homepage

    SANOFI, Level 3, One JLT, Jumeirah Lake Towers (JLT), DMCC, PO Box 53899, Dubai, UAE | Tel.: +971 4 550 3600 | Fax: +971 4 5521050

    For further Medical Information: please contact: 800 MEDICAL Toll-Free Number,

    Email: medical-information.gulf@sanofi.com

    To report an adverse event: please call: +971 561747001 or

    Email: Gulf.pharmacovigilance@sanofi.com

    To report any product technical complaints, kindly contact:

    Email: quality.greatergulf@sanofi.com

    MAT-AE-2100444/V2/Nov 2021

    • Legal notice
    • Cookie policy
    • Privacy policy
    • Sitemap
    • Change country

    YOU WILL NOW BE LEAVING THE SITE

    By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
    Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.

    Continue
    This website is intended exclusively for healthcare professionals residing and/or working in the UAE.
     
    Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.